One of the primary challenges is the complexity of cancer itself. Cancer is not a single disease but a group of related diseases, each with its own unique characteristics. This makes the development of universal treatments difficult. Additionally, the regulatory process for approving new drugs is rigorous and time-consuming, often requiring extensive clinical trials to prove safety and efficacy.
